TSCA Section 5(a)(3)(C) Det.eriiii.ii.at.ioii for Microbial Commercial Activity Notices
(MCANs) .1-21-0005, -0006

Number: J-21-0005, -0006

TSCA Section 5(a)(3) Determination: The microorganisms are not likely to present an
unreasonable risk (5(a)(3)(C))

Chemical Name:

Generic: Modified Saccharomyces cerevisiae enhanced ethanol yield
Conditions of Use (intended, known, or reasonably foreseen)1:

Intended use(s) (generic): Manufacture for use in chemical production, consistent with the

manufacturing, processing, use, distribution, and disposal information described in the
MCANs.

Known conditions of use: Applying such factors as described in footnote 1, EPA evaluated

whether there are known conditions of use and found none.

Reasonably foreseen conditions of use(s): Applying such factors as described in footnote 1, EPA
evaluated whether there are reasonably foreseen conditions of use and found none.

Summary: The microorganisms are not likely to present an unreasonable risk based on low
human health hazard and low environmental hazard associated with the recipient microorganism
and introduced genetic material. The recipient microorganism is not pathogenic to humans or
animals and has an extensive history of safe use. The introduced genetic modifications pose low
concern for health and environmental hazard and do not include antibiotic resistance markers.

Human Health Hazard : Human health hazard is relevant to whether a new microorganism is
likely to present an unreasonable risk because the significance of the risk is dependent upon both
the hazard (e.g., pathogenicity/toxicity) of the microorganism and the extent of exposure to the
microorganism. EPA estimated the human health hazard of these microorganisms based on data
for the recipient strain as well as the genetic modifications. There is low concern for human

1	Under TSCA § 3(4), the term "conditions of use" means "the circumstances, as determined by the Administrator,
under which a chemical substance (including an intergeneric microorganism) is intended, known, or reasonably
foreseen to be manufactured, processed, distributed in commerce, used, or disposed of." In general, EPA considers
the intended conditions of use of a new chemical substance to be those identified in the section 5(a) notification.
Known conditions of use include activities within the United States that result from manufacture that is exempt from
MCAN submission requirements. Reasonably foreseen conditions of use are future circumstances, distinct from
known or intended conditions of use, under which the Administrator expects the MCAN microorganisms to be
manufactured, processed, distributed, used, or disposed of. The identification of "reasonably foreseen" conditions of
use will necessarily be a case-by-case determination and will be highly fact-specific. Reasonably foreseen
conditions of use will not be based on hypothetical or conjecture. Accordingly, EPA will apply its professional
judgment, experience, and discretion when considering such factors as evidence of current use of the new
microorganisms outside the United States, evidence that the MCAN microorganisms are sufficiently likely to be
used for the same purposes as existing microorganisms that are similar, and conditions of use identified in an initial
MCAN submission that the submitter omits in a revised MCAN. The sources EPA uses to identify reasonably
foreseen conditions of use include searches of internal confidential EPA MCAN databases (containing use
information on analogous microorganisms), other U.S. government public sources, and Internet searches.

2	A microorganism is considered to have low human health hazard if it is not known to be a frank human pathogen
that causes disease in healthy adults, and/or animal studies have demonstrated a lack of pathogenicity or toxicity; a
microorganism is considered to have high human health hazard if there is evidence of adverse effects in humans or
conclusive evidence of severe effects in animal studies. In the absence of animal data on a microorganism, EPA may
use other data or information obtained through literature searches.


-------
TSCA Section 5(a)(3)(C) Det.eriiii.ii.at.ioii for Microbial Commercial Activity Notices
(MCANs) .1-21-0005, -0006

health hazard for the microorganisms based on the recipient strain not being a human pathogen
and the introduced genetic material encoding proteins that are not expected to increase the
potential for adverse human health effects.

•j

Environmental Hazard : Environmental hazard is relevant to whether a new microorganism is
likely to present unreasonable risks because the significance of the risk is dependent upon both
the hazard (e.g., pathogenicity/toxicity) of the microorganism and the extent of exposure to the
microorganism. EPA estimated the environmental hazard of these microorganisms based on data
for the recipient strain as well as information on the genetic modifications. There is low concern
for environmental hazard for these microorganisms based on the recipient strain not being an
animal or plant pathogen and the introduced genetic material encoding proteins that are not
expected to increase the potential for adverse effects on animals or plants.

Exposure and Risk Characterization: The exposure to a new microorganism is potentially
relevant to whether a new microorganism is likely to present unreasonable risks because the
significance of the risk is dependent upon both the hazard (e.g., pathogenicity/toxicity) of the
microorganism and the nature and extent of exposure to the substance.

EPA considers workers to be a potentially exposed or susceptible subpopulation (PESS) on the
basis of greater exposure potential compared to the general population. EPA also considers PESS
in conducting general population drinking water exposures by evaluating risks associated with
water intake rates for multiple age groups, ranging from infants to adults. EPA considers
consumers of specific products to be a potentially exposed or susceptible subpopulation on the
basis of greater exposure potential compared to the general population who do not use specific
products.

EPA did not estimate the occupational or environmental exposures because EPA determined that
these microorganisms present both low human health hazard and low environmental hazard. No
consumer uses were identified, so risks to consumers were not assessed.

Due to low hazard, EPA believes that these microorganisms would not be likely to present an
unreasonable risk even if exposures were high. Therefore, EPA concludes that the new
microorganisms are not likely to present unreasonable risk under the conditions of use.

4/13/2021		IsL

Date:	Madison H. Le, Director

New Chemicals Division
Office of Pollution Prevention and Toxics
U.S. Environmental Protection Agency

3 A microorganism is considered to be of low ecological hazard if it is not known to be an animal or plant pathogen,
and the genetic modifications do not impart pathogenic or toxigenic traits, and the introduced genetic material does
not provide a selective growth advantage in outcompeting indigenous microbial communities in the environment.


-------